— Know what they know.
Not Investment Advice

SLS Short Interest

SELLAS Life Sciences Group, Inc.
1W: +1.6% 1M: +5.0% 3M: +20.5% YTD: +179.8% 1Y: +511.6% 3Y: +1173.7% 5Y: +35.5%
$12.17
+0.83 (+7.32%)
 
Weekly Expected Move ±12.8%
$9 $10 $12 $13 $14
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 45 · $2.5B mcap · 200M float · 3.82% daily turnover · Short 58% of daily vol
Credit Risk of going bust: lower than 68% of companies Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down more than 99.9%), SELLAS Life Sciences Group, Inc. would be worth roughly what it owes.
Total debt $737K against a stock market value of $2.46B.
Distance to default 7.32 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $658K (short-term plus half of long-term), stock volatility 105.3%; Altman Z'' 16.73. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Short Volume Summary

2026-10-26
59.2%
Short Ratio
of total volume
60.2%
20-Day Avg
60.8%
50-Day Avg
▼ Falling
5-Day Trend
0.9M
Short Volume
1.5M
Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-26
ExchangeShort VolumeTotal VolumeShort %
NASDAQ 824,587 1,365,521 60.4%
NYSE 53,252 118,040 45.1%
BATS 8,286 12,640 65.5%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms